CAPS2 Protein Controls Oxytocin Release — Disruption Impairs Social Behavior | Research

The takeaway

The CAPS2 protein is critical for releasing oxytocin from the brain, and mice lacking CAPS2 in oxytocin neurons show impaired social behavior that can be rescued with intranasal oxytocin.

Release failure, not production
CAPS2-deficient mice had MORE stored oxytocin but LESS circulating oxytocin — the problem was release, not production

What the researchers found

CAPS2 knockout mice had reduced plasma but increased hypothalamic/pituitary oxytocin levels (release failure). OXT neuron-specific CAPS2 deletion impaired social interaction and recognition, which was rescued by intranasal oxytocin administration.

Why it matters

Understanding how oxytocin release is regulated could lead to treatments for social behavior disorders including autism. If the problem is release rather than production, therapies could target the release mechanism or bypass it with exogenous oxytocin.

The numbers in context

Reduced plasma OXT; increased hypothalamic/pituitary OXT; impaired social interaction and recognition; intranasal OXT rescue; CAPS2 expressed in hypothalamic OXT neurons

How the study worked

Animal study. CAPS2 knockout and conditional knockout mice (OXT neuron-specific). Plasma and tissue oxytocin levels measured. Social behavior testing. Intranasal oxytocin rescue experiment. CAPS2 localization in hypothalamic OXT neurons and pituitary.

Who was studied

CAPS2 knockout and conditional knockout mice

What this study cannot tell us

Mouse model — social behavior in mice may not fully represent human social interaction. CAPS2 mutations are rare in autism. Intranasal oxytocin delivery to the brain in humans remains debated. Long-term effects of oxytocin rescue not assessed.

How to read the evidence

Moderate evidence: well-designed genetic study with conditional knockout and rescue experiments, but limited to mouse models of social behavior.

When this study was published

Published 2021. Oxytocin release mechanisms continue to be studied as potential therapeutic targets for social behavior disorders.

The bigger picture

This study shifts the focus from oxytocin levels to oxytocin release mechanisms. If some people with social behavior difficulties have adequate oxytocin production but impaired release (due to CAPS2 or similar proteins), targeted therapies could unlock their existing oxytocin stores.

Questions still open

Do some people with autism have CAPS2-related oxytocin release deficits?
Could drugs that enhance CAPS2 function boost natural oxytocin release?
Does the intranasal oxytocin rescue persist long-term, or does it require continuous administration?

Common questions

What does CAPS2 have to do with social behavior?

CAPS2 is a protein that helps nerve cells release neuropeptides like oxytocin. Without CAPS2, oxytocin gets made but stays trapped inside cells. Since oxytocin is crucial for social bonding and interaction, disrupted release leads to social behavior problems in mice.

Could this help understand autism?

Possibly. CAPS2 gene alterations have been found in some people with autism. If impaired oxytocin release contributes to social difficulties in autism, therapies targeting the release mechanism — or bypassing it with intranasal oxytocin — could be beneficial.

Read the original research

CAPS2 Deficiency Impairs the Release of the Social Peptide Oxytocin, as Well as Oxytocin-Associated Social Behavior.

The Journal of neuroscience : the official journal of the Society for Neuroscience, 41(20), 4524-4535

View on PubMed ↗Publisher’s paper ↗

Citation

Fujima, Shuhei; Yamaga, Ryosuke; Minami, Haruka; Mizuno, Shota; Shinoda, Yo; Sadakata, Tetsushi; Abe, Manabu; Sakimura, Kenji; Sano, Yoshitake; Furuichi, Teiichi. (2021). CAPS2 Deficiency Impairs the Release of the Social Peptide Oxytocin, as Well as Oxytocin-Associated Social Behavior.. The Journal of neuroscience : the official journal of the Society for Neuroscience, 41(20), 4524-4535. https://doi.org/10.1523/JNEUROSCI.3240-20.2021